D.C. Mun. Regs. tit. 22, r. 22-B422
If the Director determines that a drug is adulterated or misbranded, the Director may order that the drug be removed from availability for distribution, sale, consumption, or use, or that the drug be destroyed or embargoed.
A person subject to an embargo shall be notified in writing of the action being taken and the basis of the action.
Whenever a drug is embargoed the Director shall order the drug be segregated and isolated from other drug products, affixed with a tag or other appropriate marking giving notice that the drug is, or is suspected of being, adulterated or misbranded.
The Director may continue to order the embargo of the drug until a sample has been analyzed by a qualified person designated by the Director.
If the Director determines that an embargoed drug is not adulterated or misbranded, he or she shall notify the person subject to the embargo that the tag or other marking may be removed.
If the Director determines that an embargoed drug is adulterated or misbranded the Director shall order that the drug be permanently removed from availability for distribution, sale, consumption, or use in the District of Columbia, or that the drug be destroyed.
It is unlawful for any person to remove or dispose of a drug that has been embargoed without permission from the Director.
D.C. Mun. Regs. tit. 22, r. 22-B422